A clinical pharmacologist's view of drug hepatotoxicity
- 1 January 1977
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 9 (1) , 1-15
- https://doi.org/10.1016/s0031-6989(77)80049-0
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Quinidine-lnduced Granulomatous HepatitisAnnals of Internal Medicine, 1974
- Peliosis Hepatis Associated with Androgenic-Anabolic Steroid TherapyAnnals of Internal Medicine, 1974
- Oxacillin-Induced Hepatic DysfunctionPublished by American Medical Association (AMA) ,1973
- Validity of Serum Glutamic Oxalacetic Transaminase Determinations in Isoniazid Recipients1–3American Review of Respiratory Disease, 1973
- Methotrexate Hepatotoxicity in Psoriasis--Comparison of Different Dose RegimensBMJ, 1972
- Changes in Liver and Spleen Scans of Patients During Treatment with Two Hypolipidemic DrugsRadiology, 1971
- Comparative clinical therapeutic trial with two hypolipidemic drugs: Clofibrate and nafenopinClinical Pharmacology & Therapeutics, 1971
- Iatrogenic aberrations of serum enzyme activityClinical Biochemistry, 1968
- Sulfonamide Hepatic InjuryNew England Journal of Medicine, 1967
- LIVER ENLARGEMENT AND DRUG TOXICITYMedicine, 1967